共 50 条
[32]
Fingolimod treatment for multiple sclerosis patients. Infectiological aspects and recommendations for vaccinations
[J].
NERVENARZT,
2012, 83 (02)
:236-+
[34]
No Impact of Long-Term Fingolimod Treatment on Fecal Secretory Immunoglobulin A Levels in Patients With Multiple Sclerosis
[J].
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY,
2020, 8
[37]
Natalizumab versus fingolimod and dimethyl fumarate in multiple sclerosis treatment
[J].
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY,
2019, 6 (02)
:252-262
[40]
Patient experience and practice trends in multiple sclerosis - clinical utility of fingolimod
[J].
PATIENT PREFERENCE AND ADHERENCE,
2015, 9
:685-693